ArticleJACC. Case reports2026
Takotsubo Cardiomyopathy-Induced Conduction System Quiescence With Concomitant Fascicular Ventricular Tachycardia and Complete Heart Block.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTakotsubo cardiomyopathy (TCM) is a stress-induced cardiomyopathy that mimics acute coronary syndrome without obstructive coronary artery disease. Complications include persistent, life-threatening arrhythmias, even after ejection fraction recovery. CASE SUMMARY: A 73-year-old woman presented with syncope, and electrocardiogram showed alternating wide complex tachycardia and complete heart block (CHB) (heart rate: 30-150 beats/min). Transthoracic echocardiography showed a left ventricular ejection fraction of 15% with apical/mid akinesis and basal hyperkinesis, and left heart catheterization showed nonobstructive coronary artery disease. Persistent ventricular tachycardia and CHB precluded antiarrhythmic therapy. After failing biventricular capture given an electrically quiescent conduction system, a dual-chamber implantable cardioverter-defibrillator was placed. DISCUSSION: Catecholamine excess in TCM induces microvascular dysfunction, leading to both tachy- and bradyarrhythmias, likely from catecholamine-induced electrical instability and concomitant vagal stimulation. Although most arrhythmias in TCM are transient, CHB requires permanent pacing, suggesting residual electrical remodeling despite ejection fraction recovery and highlighting a potential role for autonomic modulators. TAKE-HOME MESSAGE: TCM causes reversible left ventricular dysfunction, but persistent conduction disease highlights the need for intervention and device implantation, and further study is needed to guide pacing strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.